APG Asset Management US’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
APG Asset Management US's DGX Position: Q4 2025 in Review
APG Asset Management US sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 2,300 shares — an estimated $419K sold.
APG Asset Management US first reported a position in DGX in Q4 2024 and held it in 4 quarters. The position peaked at $419K in Q3 2025. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- APG Asset Management US reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
- APG Asset Management US sold 2,300 Quest Diagnostics shares in Q4 2025, an estimated $419K.
- APG Asset Management US first reported a position in Quest Diagnostics in Q4 2024 and held it in 4 quarters.
- APG Asset Management US's Quest Diagnostics position peaked at $419K in Q3 2025.
- 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.